187 related articles for article (PubMed ID: 20056618)
1. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):9-17. PubMed ID: 20056618
[TBL] [Abstract][Full Text] [Related]
2. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
3. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
[TBL] [Abstract][Full Text] [Related]
4. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
[TBL] [Abstract][Full Text] [Related]
5. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Jayachandran J; Bañez LL; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ;
Cancer; 2009 Nov; 115(22):5263-71. PubMed ID: 19670453
[TBL] [Abstract][Full Text] [Related]
6. Obesity, race, and long-term prostate cancer outcomes.
Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
[TBL] [Abstract][Full Text] [Related]
7. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
Cancer; 2007 Nov; 110(10):2202-9. PubMed ID: 17876838
[TBL] [Abstract][Full Text] [Related]
8. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.
Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Elashoff D; Terris MK
J Clin Oncol; 2004 Feb; 22(3):446-53. PubMed ID: 14691122
[TBL] [Abstract][Full Text] [Related]
9. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Chu DI; Moreira DM; Gerber L; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
Cancer; 2012 Oct; 118(20):4999-5007. PubMed ID: 22415377
[TBL] [Abstract][Full Text] [Related]
10. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database.
Kane CJ; Im R; Amling CL; Presti JC; Aronson WJ; Terris MK; Freedland SJ;
Urology; 2010 Sep; 76(3):695-700. PubMed ID: 20394969
[TBL] [Abstract][Full Text] [Related]
12. Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J; Young D; Chen Y; Degon M; Farrell J; Sedarsky J; Baptiste W; Rosen P; Tolstikov V; Kiebish M; Kagan J; Srivastava S; Kuo HC; Moncur JT; Rosner IL; Narain N; Akmaev V; Petrovics G; Dobi A; McLeod DG; Srivastava S; Sesterhenn IA
Eur Urol Focus; 2018 Dec; 4(6):818-824. PubMed ID: 28753864
[TBL] [Abstract][Full Text] [Related]
13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
14. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
[TBL] [Abstract][Full Text] [Related]
15. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227
[TBL] [Abstract][Full Text] [Related]
17. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
18. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Amling CL; Dorey F; Kane CJ; Presti JC; Terris MK; Aronson WJ;
Urology; 2002 Oct; 60(4):670-4. PubMed ID: 12385931
[TBL] [Abstract][Full Text] [Related]
19. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.
Chang SL; Freedland SJ; Terris MK; Aronson WJ; Kane CJ; Amling CL; Presti JC
Urology; 2010 Feb; 75(2):439-44. PubMed ID: 19819536
[TBL] [Abstract][Full Text] [Related]
20. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.
Amling CL; Riffenburgh RH; Sun L; Moul JW; Lance RS; Kusuda L; Sexton WJ; Soderdahl DW; Donahue TF; Foley JP; Chung AK; McLeod DG
J Clin Oncol; 2004 Feb; 22(3):439-45. PubMed ID: 14691120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
